MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ARTH Arch Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

ARTH is expected to report earnings to fall 20,100.00% to $2.00 per share on March 01

Arch Therapeutics, Inc. ARTH Stock Earnings Reports
Q4'22
Est.
$2.00
Q3'22
Est.
$-0.01
Q2'22
Beat
by $0.01
Q1'22
Beat
by $0.01
The last earnings report on November 30 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 14.50K shares outstanding, the current market capitalization sits at 1.11M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ARTH and Stocks

Correlation & Price change

A.I.dvisor tells us that ARTH and ALT have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and ALT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTH
1D Price
Change %
ARTH100%
-11.35%
ALT - ARTH
24%
Poorly correlated
-11.19%
EVGN - ARTH
20%
Poorly correlated
-6.91%
AAVXF - ARTH
12%
Poorly correlated
N/A
BIVI - ARTH
11%
Poorly correlated
-6.74%
APLIF - ARTH
11%
Poorly correlated
-0.44%
More